Nitric Oxide Impairs Normoxic Degradation of HIF-1α by Inhibition of Prolyl Hydroxylases
Open accessThe DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.
Abstract
Hypoxia inducible factor-1 (HIF-1) is the master regulator of metabolic adaptation to hypoxia. It is appreciated that HIF-1alpha accumulation is achieved under normoxic conditions by e.g., nitric oxide. We determined molecular mechanisms of HIF-1alpha accumulation under the impact of S-nitrosoglutathione (GSNO). In human embryonic kidney cells GSNO provoked nuclear accumulation of HIF-1alpha. This appeared unrelated to gene transcription and protein translation, thus pointing to inhibition of HIF-1alpha degradation. Indeed, GSNO as well as the hypoxia mimic CoCl2 decreased ubiquitination of HIF-1alpha and GSNO-induced HIF-1alpha failed to coimmunoprecipitate with pVHL (von Hippel Lindau protein). Considering that HIF-1alpha-pVHL interactions require prolyl hydroxylation of HIF-1alpha, we went on to demonstrate inhibition of HIF-1alpha prolyl hydroxylases (PHDs) by GSNO. In vitro HIF-1alpha-pVHL interactions revealed that GSNO dose-dependently inhibits PHD activity but not the interaction of a synthetic peptide resembling the hydroxylated oxygen-dependent degradation domain of HIF-1alpha with pVHL. We conclude that GSNO-attenuated prolyl hydroxylase activity accounts for HIF-1alpha accumulation under conditions of NO formation during normoxia and that PHD activity is subject to regulation by NO.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In line with earlier findings (Metzen et al., 2003), we observed that LPS-triggered HIF1 a accumulation was partially reduced in DC treated with the inducible nitric oxide (NO) synthase 2 ( Nos2 ) inhibitor L-NIL (Figures 2L and S2D).”
From Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1α upon LPS Activation in the Presence of Ample Oxygen (2015) · cites this paper as Metzen et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 2×
“The impact of GSNO on PHD activity was tested in a GalDBD-HIF-1 549–582-pVHL in vitro interaction assay, performed as described previously (Jaakkola et al., 2001).”
BackgroundMethodThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · cited 2×
“The requirement of pVHL for HIF-1 degradation is underscored in cells that do not contain a functional pVHL, which leads to high levels of HIF-1 in normoxia (Maxwell et al., 1999; Krieg et al., 2000; Clifford et al., 2001).”
BackgroundHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 2×
“In normoxia HIF-1α is hydroxylated at Pro564 and Pro402 which is required for pVHL binding (Ivan et al., 2001; Jaakkola et al., 2001; Masson et al., 2001; Yu et al., 2001).”
BackgroundEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Self-citationBiochemistry of nitric oxide and its redox-activated forms
Stamler, J. S., Singel, D. J., & Loscalzo, J. (1992) · Science · doi:10.1126/science.1281928 · Cited by 2,744
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549 · cited 1×
“The human enzymes have been termed prolyl hydroxylase domain containing protein 1, 2, and 3 (PHD1, PHD2, and PHD3; Epstein et al., 2001) or HIF1 prolyl hydroxylase 1, 2, and 3 (Bruick and McKnight, 2001).”
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113 · cited 1×
“Consequently, HIF-1 is polyubiquitinated and degraded by the 26S proteasome system, thus accounting for its low normoxic level of expression (Salceda and Caro, 1997; Huang et al., 1998; Kallio et al., 1999).”
BackgroundPurification and Characterization of Hypoxia-inducible Factor 1
Wang, G. L., & Semenza, G. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1230 · Cited by 2,073 · cited 1×
“HIF-1 is composed of the two basic helix-loop-helix-Per-Arnt-Sim (bHLH-PAS) proteins HIF-1 and the aryl hydrocarbon receptor nuclear translocator (ARNT), also known as HIF-1 (Wang and Semenza, 1995).”
BackgroundChandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000
Cited by
Items 201–300 of 411
Hypoxia inducible factor-1 alpha stabilization for regenerative therapy in traumatic brain injury
Khan, M., Khan, H., Singh, I., & Singh, A. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.206632 · Cited by 46
“HIF-1α and its regulating enzymes, including prolyl-4-hydroxylases (PHDs), are directly regulated by S-nitrosylation (Metzen et al., 2003), leading to stabilization of HIF1α and induction of neurorepair mechanisms in the repair phase.”
BackgroundInfluentialNitric oxide causes macrophage migration via the HIF-1-stimulated small GTPases Cdc42 and Rac1
Zhou, J., Dehne, N., & Brüne, B. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.006 · Cited by 43
Self-citationImpact of hypoxia inducible factors on estrogen receptor expression in breast cancer cells
Wolff, M., Kosyna, F. K., Dunst, J., JELKMANN, W. E. B., & Depping, R. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.11.002 · Cited by 42
Self-citationMartínez‐Romero, R., Martínez‐Lara, E., Aguilar‐Quesada, R., Peralta, A., Oliver, F. J., & Siles, E. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21781 · Cited by 43
“E-mail: esiles@ujaen.es Received 5 November 2007; Accepted 12 March 2008 DOI 10.1002/jcb.21781 hydroxylated by HIF-1 prolyl hydroxylases (PHD), ubiquitinated by the von Hippel– Lindau protein and rapidly degraded by the proteosome [Epstein et al., 2001; Metzen et al., 2003a].”
BackgroundMethodInfluentialNitric oxide signaling in human ovarian cancer: A potential therapeutic target
El‐Sehemy, A., Postovit, L.-M. M., & Fu, Y. (2016) · Nitric Oxide · doi:10.1016/j.niox.2016.02.002 · Cited by 39
Burnley-Hall, N., Willis, G. R., Davis, J., Rees, A., & James, P. E. (2016) · Nitric Oxide · doi:10.1016/j.niox.2016.12.005 · Cited by 41
Hypoxia‐Inducible Factor‐1α Under the Control of Nitric Oxide
Brüne, B., & Zhou, J. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35024-6 · Cited by 46
Self-citationCrosstalk between oxygen- and nitric oxide-dependent signaling pathways in angiogenesis
Fraisl, P. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.02.010 · Cited by 38
Epigenetic regulation of hypoxia inducible factor in diseases and therapeutics
Nguyen, M. P., Lee, S., & Lee, Y. M. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0058-x · Cited by 40
“Furthermore, PHD2 and PHD3 have been reported to be expressionally up-regulated under hypoxic conditions (Epstein et al. 2001; Metzen et al. 2003).”
BackgroundNitric oxide produced by cytochrome c oxidase helps stabilize HIF-1α in hypoxic mammalian cells
Ball, K. A., Nelson, A. W., Foster, D. G., & Poyton, R. Ο. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.050 · Cited by 40
“It is not yet clear how NO inhibits PHDs but it has been proposed to compete with O2 for binding to the ferrous iron at the active site on these enzymes [28].”
BackgroundMitochondria: Oxygen sinks rather than sensors?
Wenger, R. H. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.047 · Cited by 42
“For instance, they are sensitive to changes in ascorbate, nitric oxide and transition metal levels [34-37].”
BackgroundThe role of hypoxia-inducible factor 1 alpha (HIF-1α) modulation in heavy metal toxicity
Aschner, M., Skalny, A. V., Lu, R., Santamaría, A., Zhou, J., Ke, T., Karganov, M. Y., Tsatsakis, A. M., Golokhvast, K. S., Bowman, A. B., et al. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03483-7 · Cited by 43
Self-citationDifferential but complementary roles of HIF-1α and HIF-2α in the regulation of bone homeostasis
Lee, S. Y., Kim, S., Park, K. H., Lee, G., Oh, Y., Ryu, J., & Huh, Y. H. (2024) · Communications Biology · doi:10.1038/s42003-024-06581-z · Cited by 46
“Under normoxia, the proline residues of the HIF-α subunit are hydroxylated by prolyl-4-hydrolyase (PHD) fol-lowinginteractionwithvonHippel-Lindau (VHL), speci fi cE3ligase,and then polyubiquitination and proteasomal degradation 10 .”
Kitajima, S., Lee, K. L., Hikasa, H., Sun, W., Huang, R. Y., Yang, H. H., Matsunaga, S., Yamaguchi, T., Araki, M., Kato, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23010 · Cited by 35
“It is important to note that consistent with previous studies [26, 27], we observed elevated levels of cellular nitric oxide (NO) upon NH4Cl treatment (Figure 2G), which might lead to PHD inhibition [28].”
ResultA potential role for inducible nitric oxide synthase in the cerebral response to acute hemodilution
McLaren, A. T., Mazer, C. D., Zhang, H., Liu, E., Mok, L., & Hare, G. M. T. (2009) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-009-9104-z · Cited by 33
Inactivated tumor suppressor Rb by nitric oxide promotes mitosis in human breast cancer cells
Radisavljevic, Z. M. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20063 · Cited by 36
“On the other hand, NOdecreases ubiquitination anddegradationof hypoxia inducible factor-1a (HIF-1a), a regulator of metabolic adaptation to hypoxia, involved in angiogenesis and highly expressed in hypoxic area in tumor distinct from microvessels [Metzen et al., 2003].”
BackgroundRb1 postconditioning attenuates liver warm ischemia–reperfusion injury through ROS-NO-HIF pathway
Guo, Y., Yang, T., Lu, J. L., Li, S., Wan, L., Long, D., Li, Q., Li, F., & Li, Y. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.01.022 · Cited by 35
“Under normoxia, NO can block PHD activity by interacting with enzyme bound Fe2+, directly attenuate hydroxylation of HIF-1alpha (Metzen et al., 2003; Li et al., 2007) and accumulate HIF-1alpha.”
BackgroundHypoxia-Inducible Factors: Post-translational Crosstalk of Signaling Pathways
Dimova, E. Y., & Kietzmann, T. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-738-9_13 · Cited by 37
Frede, S., Stockmann, C., Winning, S., Freitag, P., & Fandrey, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802378 · Cited by 35
Self-citationRetractedThe hypoxic response and aging
Kaeberlein, M. R., & Kapahi, P. (2009) · Cell Cycle · doi:10.4161/cc.8.15.9126 · Cited by 40
AKT as locus of cancer multidrug resistance and fragility
Radisavljevic, Z. M. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24176 · Cited by 34
Vascular Endothelial Growth Factor—A Positive and Negative Regulator of Tumor Growth
Vecchiarelli-Federico, L. M., Cervi, D. N., Haeri, M., Li, Y., Nagy, A., & Ben‐David, Y. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3592 · Cited by 38
“In turn, this induces the activation of HIF-1α (20) and prevents the degradation of these tumor inhibitory myeloid cells (21).”
BackgroundInduction of the nuclear factor HIF-1α in acetaminophen toxicity: Evidence for oxidative stress
James, L. P., Donahower, B., Burke, A. S., McCullough, S. S., & Hinson, J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.143 · Cited by 36
Giacomo, G. D., Rizza, S., Montagna, C., & Filomeni, G. (2012) · International Journal of Cell Biology · doi:10.1155/2012/361872 · Cited by 33
“Even under normoxic conditions, NO positively affects HIF-1 stabilization by indirectly inhibiting PHDs activity [129]; however, it has been also indicated that NO can directly impact on HIF1α subunit by means of S-nitrosylation reactions on specific cysteines, thereby enhancing its stability and gene transactivating…”
BackgroundMultifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment
Lappano, R., Todd, L. A., Stanic, M., Cai, Q., Maggiolini, M., Marincola, F., & Pietrobon, V. (2022) · Cancers · doi:10.3390/cancers14030539 · Cited by 32
Nitric oxide and hydrogen sulfide: Sibling rivalry in the family of epigenetic regulators
Kuschman, H. P., Palczewski, M. B., & Thomas, D. D. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.010 · Cited by 34
Microenvironmental adaptation of experimental tumours to chronic vs acute hypoxia
Thews, O., Wolloscheck, T., Dillenburg, W., Kraus, S., Kelleher, D. K., Konerding, M. A., & Vaupel, P. W. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602066 · Cited by 36
“Since the HIF-1a level was not determined in the present study, it remains unclear whether hypoxia in vivo leads to HIF-1 accumulation (either directly or indirectly by increasing the NO concentration; Metzen et al, 2003) in the tumour model used.”
Martínez‐Romero, R., Cañuelo, A., Siles, E., Oliver, F. J., & Martínez‐Lara, E. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00898.2011 · Cited by 33
Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells
Oszajca, K., Bieniasz, M., Brown, G., Świątkowska, M., Bartkowiak, J., & Szemraj, J. (2008) · Biochemistry and Cell Biology · doi:10.1139/o08-137 · Cited by 34
“Consequently, some studies support our findings (Umansky et al. 1998; Takada et al. 2003; Mendes et al. 2002; Martin et al. 2005; Metzen et al. 2003; Sandau et al. 2001; Simon 2006), whereas others refute them (Reynaert et al. 2004; Nikitovic et al. 1998; Mateo et al. 2003; Korn et al. 2001).”
ResultMartínez‐Romero, R., Cañuelo, A., Martínez‐Lara, E., Oliver, F. J., Cárdenas, S., & Siles, E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06307.x · Cited by 35
“Hypoxia-inducible factor-1 transcriptional activity is regulated by FIH, the transcription of which appears to be independent of the oxygen concentration (Metzen et al. 2003).”
BackgroundThe mitochondrial thioredoxin system regulates nitric oxide-induced HIF-1α protein
Zhou, J., Chantzoura, E., Spyrou, G., & Brüne, B. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.09.012 · Cited by 32
Self-citationHypoxia-inducible factors: Crosstalk between their protein stability and protein degradation
Wei, W., & Yu, X. D. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.08.009 · Cited by 36
HIF-1α represses the expression of the angiogenesis inhibitor thrombospondin-2
MacLauchlan, S., Calabro, N. E., Huang, Y., Krishna, M., Bancroft, T. A., Sharma, T., Yu, J., Sessa, W. C., Giordano, F. J., & Kyriakides, T. R. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.07.002 · Cited by 35
Cervoni, M. S., Cardoso-Júnior, C. A. M., Craveiro, G. M., Souza, A. D. O., Alberici, L. C., & Hartfelder, K. (2017) · Journal of Experimental Biology · doi:10.1242/jeb.161844 · Cited by 44
“In other animal models, such changes were shown to be strongly associated with NO signaling (Mateo et al., 2003; Metzen et al., 2003), but this does not seem to be the case in honey bee workers.”
BackgroundCarvalho, E. M., Sousa, E. H. S., Bernardes‐Génisson, V., & Lopes, L. G. D. F. (2021) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.202100527 · Cited by 33
Corti, A., Franzini, M., Scataglini, I., & Pompella, A. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.08.002 · Cited by 35
Hypoxia-inducible factor prolyl 4-hydroxylase inhibition in cardiometabolic diseases
Koivunen, P., Serpi, R., & Dimova, E. Y. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.003 · Cited by 38
GSNO promotes functional recovery in experimental TBI by stabilizing HIF-1α
Khan, M., Dhammu, T. S., Baarine, M., Kim, J., Paintlia, M. K., Singh, I., & Singh, A. K. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.10.037 · Cited by 29
YAP nuclear translocation induced by HIF-1α prevents DNA damage under hypoxic conditions
Chang, H.-A., Yang, R.-Z. O., Su, J.-M., Nguyen, T. M. H., Sung, J., Tang, M., & Chiu, W. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01687-5 · Cited by 37
Reactive Oxygen Species-independent Oxidation of Thioredoxin in Hypoxia
Muniyappa, H., Song, S., Mathews, C. K., & Das, K. C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.008557 · Cited by 29
AKT as locus of cancer angiogenic robustness and fragility
Radisavljevic, Z. M. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24115 · Cited by 29
“Other authors concluded that AKT sensitizes cells to oxidative apoptosis (Nogueira et al., 2008), instead that AKT does not determines oxidative response nor sensitizes cells to oxidative apoptosis, but rather balance of the oxidants/antioxidants determines response of the AKT in cancer system…”
BackgroundOrtiz‐Masiá, D., Hernández, C., Quintana, E., Veiázquez, M., Cebrián, S., Riaño, A., Calatayud, S., Esplugues, J. V., & Barrachina, M. D. (2009) · The FASEB Journal · doi:10.1096/fj.09-137489 · Cited by 29
Insights on the functional dualism of nitric oxide in the hallmarks of cancer
Panneerselvan, P., Vasanthakumar, K., Muthuswamy, K., Vasanth, K., & Selvakumar, S. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189001 · Cited by 29
Wagner, K., Gröger, M., McCook, O., Scheuerle, A., Asfar, P., Stahl, B., Huber-Lang, M. S., Ignatius, A. A., Jung, B., Duechs, M. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132810 · Cited by 27
Schneider, M., Harnoss, J. M., Strowitzki, M. J., Radhakrishnan, P., Platzer, L. K., Harnoss, J. C., Hank, T. P., Cai, J., & Ulrich, A. B. (2015) · Hypoxia · doi:10.2147/hp.s60872 · Cited by 28
“oxide (by chelating Fe[II]), emphasizing the crucial effects of oxidative stress on the PHD–HIF axis.(25,26)”
Kaluz, Š., Kaluzová, M., & Stanbridge, E. J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21644 · Cited by 31
“There is evidence that NO regulates the HIF system [Metzen et al., 2003], presumably because it can act, at sufficiently high concentrations, as an analog of molecular O2 and inhibit 2OG-dependent oxygenases.”
BackgroundCallier, V., & Nijhout, H. F. (2014) · Current Opinion in Insect Science · doi:10.1016/j.cois.2014.05.007 · Cited by 28
Minocycline inhibits angiogenesis in vitro through the translational suppression of HIF-1α
Jung, H.-J., Seo, I., Jha, B. K., Suh, S.-I., Suh, M.-H., & Baek, W.-K. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.12.023 · Cited by 27
Beltrán-Povea, A., Caballano‐Infantes, E., Salguero‐Aranda, C., Martín, F., Soria, B., Bedoya, F. J., Tejedo, J. R., & Cahuana, G. M. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i3.605 · Cited by 28
Macrophage NOS2 in Tumor Leukocytes
Brüne, B., Courtial, N., Dehne, N., Syed, S. N., & Weigert, A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6811 · Cited by 30
“This iron center renders PHDs sensitive to NO and indeed NO inhibits PHDs to provoke HIF-1 a and HIF-2 a accumulation (123, 158).”
Self-citationAmperometric sensing of HIF1α expressed in cancer cells and the effect of hypoxic mimicking agents
Hussain, K. K., Gurudatt, N. G., Mir, T. A., & Shim, Y. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.04.068 · Cited by 26
“There are various factors responsible for enhancing HIF1α expression, including desferrioxamine (Wang and Semenza, 1993), growth factors (Maxwell et al., 2001), nitric oxide (Metzen et al., 2003), and transition metal ions (Galanis et al., 2009).”
BackgroundPresley, T. D., Vedam, K., Velayutham, M., Zweier, J. L., & Ilangovan, G. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00550.2007 · Cited by 29
Dragowska, W. H., Warburton, C., Yapp, D. T. T., Minchinton, A. I., Hu, Y., Waterhouse, D., Gelmon, K. A., Skov, K. A., Woo, J., Masin, D., et al. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.606.2.11 · Cited by 26
“48), and the presence of cytokines, nitric oxide, and transition metals such as Co (49).”
BackgroundDirect effects of hypoxia and nitric oxide on ecdysone secretion by insect prothoracic glands
DeLalio, L. J., Dion, S. M., Bootes, A. M., & Smith, W. A. (2015) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2015.02.009 · Cited by 28
Response to stress in biological disorders: Implications of stress granule assembly and function
Wang, L., Yang, W., Li, B., Yuan, S., & Wang, F. (2021) · Cell Proliferation · doi:10.1111/cpr.13086 · Cited by 29
Determinants of hypoxia-inducible factor activity in the intestinal mucosa
Fagundes, R. R., & Taylor, C. T. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00203.2017 · Cited by 28
Nitric Oxide Signaling and Sensing in Age-Related Diseases
Mazuryk, O., Gurgul, I., Oszajca, M., Polaczek, J., Kieca, K., Bieszczad-Żak, E., Martyka, T., & Stochel, G. (2024) · Antioxidants · doi:10.3390/antiox13101213 · Cited by 37
Mechanism and regulation of iron absorption throughout the life cycle
Qiu, L., Frazer, D. M., Hu, M., Song, R., Liu, X., Qin, X., Ma, J., Zhou, J., Tan, Z., Ren, F., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.01.002 · Cited by 38
Self-citationRedoxins in peripheral neurons after sciatic nerve injury
Valek, L., Kanngießer, M., Häußler, A., Agarwal, N. K., Lillig, C. H., & Tegeder, I. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.09.008 · Cited by 25
Bonfili, L., Gong, C., Lombardi, F., Cifone, M. G., & Eleuteri, A. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010357 · Cited by 35
“Several factors, such as ROS [23] and NO [24], can interfere with PHD activity finally influencing HIF-stability.”
BackgroundThe Role of Nitric Oxide in Stem Cell Biology
Caballano‐Infantes, E., Cahuana, G. M., Bedoya, F. J., Salguero‐Aranda, C., & Tejedo, J. R. (2022) · Antioxidants · doi:10.3390/antiox11030497 · Cited by 27
Non-hypoxic activation of the negative regulatory feedback loop of prolyl-hydroxylase oxygen sensors
Tug, S., Reyes, B. D., Fandrey, J., & Berchner‐Pfannschmidt, U. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.016 · Cited by 26
Self-citationThe Antioxidant and Antiproliferative Activities of 1,2,3-Triazolyl-L-Ascorbic Acid Derivatives
Harej, A., Meščić, A., Stepanić, V., Klobučar, M., Pavelić, K., Pavelić, S. K., & Raić‐Malić, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194735 · Cited by 23
Hypoxia-Inducible Factor Stabilizers: a New Avenue for Reducing BP While Helping Hemoglobin?
Yousaf, F., & Spinowitz, B. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0629-6 · Cited by 27
Hyperbaric oxygen therapy provides neuroprotection following spinal cord injury in a rat model.
Huang, H., Xue, L., Zhang, X., Weng, Q., Chen, H., Gu, J., Ye, S., Chen, X. P., Zhang, W., & Liao, H. (2013) · Europe PMC (PubMed Central) · Cited by 23
Marcillac, F., Brix, B., Repond, C., Jöhren, O., & Pellerin, L. (2011) · Glia · doi:10.1002/glia.21240 · Cited by 25
“It has been reported that under normoxic conditions NO inhibits prolyl hydroxylases, preventing the hydroxylation and degradation of the transcription factor hypoxia GLIA inducible factor-1a (HIF-1a) (Metzen et al., 2003).”
BackgroundHypoxia Inducible Factor–Dependent Regulation of Angiogenesis by Nitro–Fatty Acids
Rudnicki, M., Faine, L. A., Dehne, N., Namgaladze, D., Ferderbar, S., Weinlich, R., Amarante-Mendes, G. P., Yan, C. Y. I., Krieger, J. E., Brüne, B., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.224626 · Cited by 24
Self-citationBorley, K. A., Beers, J. M., & Sidell, B. D. (2010) · Journal of Experimental Biology · doi:10.1242/jeb.043281 · Cited by 27
“This inhibition of PHD2 by NO results in accumulation of HIF-1a protein (Kimura et al., 2000; Kimura et al., 2001; Metzen et al., 2003).”
BackgroundHyperbaric oxygen preconditioning: a reliable option for neuroprotection
Zhang, J. H., Hu, Q., Manaenko, A., Matei, N., Guo, Z., Xu, T., & Tang, J. (2016) · Medical Gas Research · doi:10.4103/2045-9912.179337 · Cited by 25
Nitric Oxide in Hematological Cancers: Partner or Rival?
Vivarelli, S., Falzone, L., Basile, M. S., Candido, S., & Libra, M. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7958 · Cited by 24
“Between 100 and 150 n M , NO stabilizes HIF-1 a , thus increasing vascular endothelial growth factor (VEGF) production in endothelial and cancer cells, and consequent angiogenesis (117, 155).”
HIF Prolyl-4-hydroxylase Interacting Proteins: Consequences for Drug Targeting
Wenger, R. H., Camenisch, G., Stiehl, D. P., & Katschinski, D. M. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789649411 · Cited by 25
“Indeed, it has been shown that ascorbate [47], transition metals [48, 49], and reactive oxygen species (ROS) including NO [ 50-52 ] influence or completely block the activity of the PHDs, establishing a molecular cross-talk between oxygen homeostasis and redox-active substances.”
BackgroundThe role of myoglobin in epithelial cancers: Insights from transcriptomics
Bicker, A., Nauth, T., Gerst, D., Aboouf, M. A., Fandrey, J., Kristiansen, G., Gorr, T. A., & Hankeln, T. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4433 · Cited by 26
“NO· inhibits the activity of the sensor protein prolyl-hydroxylase 2 (PHd2), which is the main PdH expressed in these cell models (45,46).”
BackgroundResultSelf-citationHypoxia-inducible factors not only regulate but also are myeloid-cell treatment targets
Kling, L., Schreiber, A., Eckardt, K., & Kettritz, R. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ri0820-535r · Cited by 25
An overview of hyperbaric oxygen preconditioning against ischemic stroke
Wu, X., You, J., Chen, X., Zhou, M., Ma, H., Zhang, T., & Huang, C. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01165-y · Cited by 26
“Moreover, ROS can regulate HIF-1α by activating phosphoinositide 3-kinase/Akt (PI3K/AKT) (Gao et al. 2004), interfering with hydroxylase activity and leading to the accumulation of HIF-1α (Metzen et al. 2003).”
BackgroundEnvironmental and behavioral regulation of HIF-mitochondria crosstalk
Burtscher, J., Hohenauer, E., Burtscher, M., Millet, G. P., & Egg, M. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.06.015 · Cited by 28
Interaction of Hydrogen Sulfide with Oxygen Sensing under Hypoxia
Wu, B., Teng, H., Zhang, L., Li, H., Li, J., Wang, L., & Li, H. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/758678 · Cited by 28
The impact ofN‐nitrosomelatonin as nitric oxide donor in cell culture experiments
Berchner‐Pfannschmidt, U., Tug, S., Trinidad, B., Becker, M., Oehme, F., Flamme, I., Fandrey, J., & Kirsch, M. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00622.x · Cited by 24
“Furthermore, NO release from NOMela can elicit important effects as a strong inhibitor of the prolylhydroxylases (PHD1-3) that act as cellular O2 sensors and control the levels of the transcription factor complex hypoxia inducible factor-1 (HIF-1).”
BackgroundResultSelf-citationOuyang, D., Ji, Y., Saltis, M., Xu, L., Zhang, Y.-T., Zha, Q., Cai, J., & He, X. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.06.016 · Cited by 23
Monocyte glycolysis determines CD8+ T cell functionality in human Chagas disease
Sanmarco, L. M., Eberhardt, N., Bergero, G., Palacio, L. P. Q., Adami, P. V. M., Visconti, L. M., Minguez, Á. R., Hernández-Vásquez, Y., Silva, E. A. C., Morelli, L., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.123490 · Cited by 26
Locus of fragility in robust breast cancer system
Radisavljevic, Z. M. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20141 · Cited by 20
“On the other hand, NO decreases ubiquitination and degradation of HIF-1a, a regulator of metabolic adaptation to hypoxia [Metzen et al., 2003].”
BackgroundPark, J.-Y., Park, J., Suh, S., & Baek, W. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.129 · Cited by 21
Aggarwal, A., Singh, I., & Sandhir, R. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.05.009 · Cited by 22
Mipu1, a Novel Direct Target Gene, Is Involved in Hypoxia Inducible Factor 1-Mediated Cytoprotection
Wang, K., Lei, J., Zou, J., Xiao, H., Chen, A., Liu, X., Liu, Y., Jiang, L., Xiao, Z., & Xiao, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082827 · Cited by 19
“Since CoCl2 is an inhibitor of prolyl hydroxylases (PHDs) which hydroxylates HIF-1α protein at the proline residues leading to degradation of HIF-1α protein [24-26], it does make stable of HIF-1α protein rather than regulates the HIF-1α expression at transcriptional level.”
BackgroundRegulation of B cell functions by S-nitrosoglutathione in the EAE model
Kim, J., Islam, S. M. T., Qiao, F., Singh, A. K., Khan, M., Won, J., & Singh, I. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102053 · Cited by 20
“S-nitrosylation is known to stabilize HIF-1α protein [93] and inhibit PHD [94,95] and VHL [96] activities.”
BackgroundDetermination and Modulation of Prolyl‐4‐Hydroxylase Domain Oxygen Sensor Activity
Wirthner, R., Balamurugan, K., Stiehl, D. P., Barth, S., Spielmann, P., Oehme, F., Flamme, I., Katschinski, D. M., Wenger, R. H., & Camenisch, G. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35003-9 · Cited by 24
“…al., 2005), Krebs cycle intermediates (Dalgard et al., 2004; Lu et al., 2005; Selak et al., 2005) and reactive oxygen species (ROS) including NO (BerchnerPfannschmidt et al., 2006; Gerald et al., 2004; Metzen et al., 2003) have been shown to influence or completely block the activity of the PHDs.”
BackgroundAKT as locus of cancer positive feedback loops and extreme robustness
Radisavljevic, Z. M. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24167 · Cited by 19
Riaño, A., Ortiz‐Masiá, D., Velázquez, M., Calatayud, S., Esplugues, J. V., & Barrachina, M. D. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0374-1 · Cited by 19
A lifeline for suffocating tissues
Mazzone, M., & Carmeliet, P. (2008) · Nature · doi:10.1038/4531194a · Cited by 19
The non-canonical functions of HIF prolyl hydroxylases and their dual roles in cancer
Yu, M., Lun, J., Zhang, H., Zhu, L., Zhang, G., & Fang, J. S. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.105982 · Cited by 22
Starzyński, R. R., Gonçalves, A. S., Muzeau, F., Tyrolczyk, Z., Smuda, E., Drapier, J., Beaumont, C., & Lipiński, P. (2006) · Biochemical Journal · doi:10.1042/bj20060623 · Cited by 19
An Oxygen Molecular Sensor, the HIF Prolyl 4-Hydroxylase, in the Marine Protist Perkinsus olseni
Leite, R. B., Bensimon‐Brito, A., & Cancela, M. L. (2008) · Protist · doi:10.1016/j.protis.2008.03.002 · Cited by 17
“…show a marked effect on HPH regulation as previously described (Bruick and McKnight 2001; Dalgard et al. 2004; del Peso et al. 2003; Epstein et al. 2001; Lando et al. 2002; Mahon et al. 2001; McNeill et al. 2002; Metzen et al. 2003; Naranjo-Suarez et al. 2003; Sang et al. 2002; Tian et al. 2006).”
BackgroundMethodSumbayev, V. V., & Yasinska, I. M. (2006) · Free Radical Research · doi:10.1080/10715760600649648 · Cited by 18
Winning, S., & Fandrey, J. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0004 · Cited by 16
Self-citationOshiro, S., Ishima, Y., Maeda, H., Honda, N., Bi, J., Kinoshita, R., Ikeda-Imafuku, M., Iwao, Y., Imafuku, T., Nishida, K., et al. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.10.023 · Cited by 15
Speer, R. E., & Ratan, R. R. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-7678-9_16 · Cited by 17
Hostile takeover: Manipulation of HIF-1 signaling in pathogen-associated cancers (Review)
Zhu, C., Zhu, Q., Wang, C., Zhang, L., Wei, F., & Cai, Q. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3633 · Cited by 15
Hypoxia-Inducible Factors and Burn-Associated Acute Kidney Injury—A New Paradigm?
Enescu, D. M., Parasca, S. V., Bădoiu, S. C., Miricescu, D., Totan, A., Stănescu-Spînu, I.-I., Greabu, M., & Jinga, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052470 · Cited by 19
Miranda, K. M., Ridnour, L. A., Cheng, R. Y. S., Wink, D. A., & Thomas, D. D. (2023) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2023047302 · Cited by 13
A review on transcriptional regulation responses to hypoxia in mesenchymal stem cells
Alijani, N., Johari, B., Moradi, M., & Kadivar, M. (2019) · Cell Biology International · doi:10.1002/cbin.11211 · Cited by 15
Feng, C., Guo, J., Jiang, H., Zhu, S., Li, C., Cheng, B., Chen, Y., & Wang, H. (2007) · International Journal of Radiation Biology · doi:10.1080/09553000701616080 · Cited by 14
“Under normal oxygen conditions, some metallic ions (McNeill et al. 2002), nitrogen monoxide (Metzen et al. 2003), and cellular factors such as IL-1b (Thornton et al. 2000) and TNF-a (Albina et al. 2001), can also activate HIF-1a and induce downstream gene expression.”
Background
Metadata
- Authors
- Metzen, E., Zhou, J., Jelkmann, W., Fandrey, J., & Brüne, B.
- Affiliations
- University of Lübeck (DE)
- University of Kaiserslautern (DE)
- University of Duisburg-Essen (DE)
- Venue
- Molecular Biology of the Cell
- Published
- 2003-08
- Volume
- 14
- Issue
- 8
- Pages
- 3470-3481
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- PMC
- PMC181582
- OpenAlex
- W2072634616
- Cited by
- 414
- References
- 63
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 10 · 2023: 13 · 2022: 7 · 2021: 22 · 2020: 13 · 2019: 12 · 2018: 9 · 2017: 12 · 2016: 23 · 2015: 19 · 2014: 10 · 2013: 14 · 2012: 17
- FWCI
- 9.57
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular Biology of the Cell (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- European Molecular Biology Laboratory
- University of Oxford
- Deutsche Forschungsgemeinschaft (SFB367, BR999)
- Deutsche Krebshilfe
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- nitric oxide, HIF-1α, prolyl hydroxylase, S-nitrosoglutathione, HIF-1α degradation, ubiquitination, von Hippel-Lindau protein, oxygen-dependent degradation domain, cobalt chloride, hypoxia, protein stability
- MeSH terms
- Cells, Cultured, Humans, Nitric Oxide, Procollagen-Proline Dioxygenase, Protein Binding, Transcription Factors, Transcription, Genetic, Protein Biosynthesis, Cell Hypoxia, Tumor Suppressor Proteins, S-Nitrosoglutathione, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.